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Background: Toll-like receptors play a key role in innate immunity by recognizing pathogens and activating
appropriate responses. Pathogens express several signal molecules (pathogen-associated molecular patterns,
PAMPs) essential for survival and pathogenicity. Recognition of PAMPs triggers an array of anti-microbial immune
responses through the induction of various inflammatory cytokines. The objective of this work was to perform a
case-control study to characterize the distribution of polymorphisms in three candidate genes (toll-like receptor 2,
toll-like receptor 4, toll-like receptor 9) and to test their role as potential risk factors for tuberculosis infection in water
buffalo (Bubalus bubalis).
Results: The case-control study included 184 subjects, 59 of which resulted positive to both intradermal TB test
and Mycobacterium bovis isolation (cases) and 125 resulted negative to at least three consecutive intradermal
TB tests. The statistical analysis indicated that two polymorphisms exhibited significant differences in allelic frequencies
between cases and controls. Indeed, the TT genotype at TLR9 2340 C > T locus resulted significantly associated with
susceptibility to bovine tuberculosis (P = 0.030, OR = 3.31, 95% CI = 1.05-10.40). One polymorphism resulted
significantly associated with resistance to the disease, and included the CC genotype, at the TLR4 672 A > C
locus (P = 0.01, OR = 0.26, 95% CI = 0.08-0.80). Haplotype reconstruction of the TLR2 gene revealed one haplotype
(CTTACCAGCGGCCAGTCCC) associated with disease resistance (P = 0.04, OR = 0.51, 95% CI = 0.27? 0.96), including the
allelic variant associated with disease resistance.
Conclusions: The work describes novel mutations in bubaline TLR2, TLR4 and TLR9 genes and presents their association
with M. bovis infection. These results will enhance our ability to determine the risk of developing the disease by
improving the knowledge of the immune mechanisms involved in host response to mycobacterial infection,
and will allow the creation of multiple layers of disease resistance in herds by selective breeding.
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Tuberculosis is a major zoonosis that causes serious eco-
nomic losses in livestock industry. Among domestic ru-
minants, an economically important role, in many parts
of the world and particularly in Southern Italy, is played
by water buffalo (Bubalus bubalis). Milk from this animal
species is used for the production of the worldwide fam-
ous ? mozzarella di bufala? cheese, whose product specifi-
cations allow the use of raw milk [1]. It is therefore
mandatory the use of milk collected from brucellosis- and
tuberculosis-free herds. Tuberculosis in Southern Italy has
not yet been eradicated (prevalence of 0.7% in bovine and
water buffalo herds in 2012), and there is an increase of
new cases of the disease (incidence of 0.65%) (data from
the veterinary epidemiology monitoring field office, Isti-
tuto Zooprofilattico Sperimentale del Mezzogiorno www.
izsmportici.it). The Italian National plan for tuberculosis
control is based on a test-and-slaughter approach and
does not allow vaccination. The genetic variation within
the host may play a crucial role in the immunity to infec-
tions and resistance or susceptibility to disease, and select-
ive breeding for disease-resistant genotypes might
represent an emerging approach supporting disease con-
trol [2,3]. The role of genes in protection against bacterial
infections also shown in water buffalo [4] prompted the
search for polymorphisms conferring resistance to myco-
bacterial infection in this species.
Microbial infection initiates complex interactions be-
tween the pathogen and the host. Pathogens express sev-
eral molecules, known as pathogen-associated molecular
patterns (PAMPs), which are essential for survival and
pathogenicity. Recognition of PAMPs triggers an array of
anti-microbial immune responses through the induction
of various inflammatory cytokines [5].
Toll-like receptors (TLRs) are reported to be involved
in immune responses [6-8] and their polymorphisms have
been associated with mutated susceptibility to mycobac-
teria, the causative agent of bovine tuberculosis, both in
humans and different animal species [9-15]. TLRs are
transmembrane proteins that play a key role in innate im-
munity by recognizing pathogens and subsequently acti-
vating appropriate responses. They are characterized by
an extracellular N-terminal domain constituted by 16 to
28 leucine rich repeats (LRR) involved in ligand recogni-
tion [16], and an intracellular C-terminal domain known
as the toll/IL-1 receptor (TIR) domain, required for the
interaction and recruitment of various adaptor mole-
cules to activate the downstream signalling pathways [17].
In water buffalo, each cell contains 25 chromosome pairs
(Bubalus bubalis 2n = 50) [18], and the TLRs 2 and 9 loci
are localized on chromosomes 17 and 21, respectively, while
the TLR 4 locus is located on chromosome 3 [19].
Toll-like receptors 2 and 4 mediate their effects by recog-
nizing bacteria, including mycobacteria. Toll-like receptor 2is sensitive to peptidoglycan and to lipoarabinomannan.
Toll-like receptor 4 is involved in bacterial lipopolysac-
charide recognition [20], but its sensitivity to myco-
bacterial antigens has also been reported [21]. Toll-like
receptor 9 is essential for responses to bacterial DNA
and in particular to unmethylated CpG dinucleotides
(CpG DNA) [22].
The aim of this study was (i) to identify single nucleo-
tide polymorphisms (SNPs) in the coding sequence
(CDS) of three candidate genes: toll-like receptor 2 (TLR 2),
toll-like receptor 4 (TLR 4), toll-like receptor 9 (TLR 9),
(ii) to characterize the distribution of the detected poly-
morphisms and (iii) to perform a case-control study to
test their role as potential risk factors for tuberculosis in-
fection in water buffalo.Results
Identification of SNPs
The water buffalo TLR2 and TLR9 genes consist of two
exons, while the TLR4 consists of three exons. The ana-
lysis of the entire CDSs enabled us to identify 29 new
SNPs. Specifically, 18 were identified in TLR2 (five non-
synonymous and 13 synonymous), nine in TLR4 (five
non-synonymous and four synonymous), and two in TLR9
(both synonymous). All the found SNPs were bi-allelic
with the exception of a tri-allelic SNP (572 A > CG) found
in TLR4. In addition we identified a dinucleotidic SNP
(482/483 GC > CT) in TLR2. Table 1 shows all the SNPs,
their positions in the CDS, the encoded protein codon
and the GenBank reference number.Case-control study
Calculation of the allelic and genotypic frequencies, and
application of the χ2 test, revealed that both populations
(cases and controls) conformed to the Hardy-Weinberg
equilibrium with regard to all the polymorphic loci (P > 0.05)
of the TLRs 2, 4 and 9 genes.
As a first step of the genetic association study, Pearson? s
chi-squared test was carried out for each SNP both inde-
pendently and as genotype. As many SNPs exhibited a
strong linkage disequilibrium a multiple testing correction
was applied by permutation analysis. Within the 29
analysed polymorphic sites, three SNPs exhibited sta-
tistically significant differences in frequency distribution
of one or more associated genotypes between cases and
controls (Table 2). In particular, one SNP was located in the
TLR2 gene (1650 G >A ), one SNP in TLR4 (672 A >C)
and one in TLR9 (2340 C > T). Then, in order to test in-
heritance model, a deviation test from additivity was per-
formed with plink version 1.07, suggesting in our case
an additive model of inheritance. SNPs significantly asso-
ciated to the disease (P < 0.05) were used for further
analysis: a logistic regression model was performed to
Table 1 Detected SNPs in bubaline TLRs2, 4 and 9 genes
Gene SNPa AA changeb Protein domainc dbSNP ID
TLR2 42 C > T Silent 14 -d rs1388116474:C > T
53 C > T M18T - rs1388116475:C > T
108 C > T Silent 36 LRR 8 rs1388116476:C > T
153 G > A Silent 51 LRR_RI rs1388116477:G > A
156 C > T Silent 52 LRR_RI rs1388116478:C > T
374 T > C A125V LRR 8 rs1388116479:T > C
381 A > G Silent 127 LRR 8 rs1388116480:A > G
482/483 GC > CT S161T LRR 8 rs1388116481:GC > CT
519 G > C Silent 173 LRR_RI rs1388116482:G > C
1034 A > G S345N - rs1388116483:A > G
1375 T > C Silent 459 LRR4 rs1388116484:T > C
1407 C > T Silent 469 LRR4 rs1388116485:C > T
1650 G > A Silent 550 LRR_CT rs1388116486:G > A
1678 A > G A560T LRR_CT rs1388116487:A > G
1707 C > Te Silent 569 LRR_CT rs1388116488:C > T
1731 C > T Silent 577 LRR_CT rs1388116489:C > T
1740 C > T Silent 580 LRR_CT rs1388116490:C > T
2064 T > C Silent 688 TIR rs1388116491:T > C
TLR4 572 A > Cf Y191S LRR8 rs1388116492:A > CG
572 A > Gf silent LRR8 rs1388116492:A > CG
574 C > T Q192W LRR8 rs1388116493:C > T
575 A > G Q192W LRR8 rs1388116494:A > G
576 T > G Silent192 LRR8 rs1388116495:T > G
577 G > A E193K LRR8 rs1388116496:G > A
579 A > G Silent193 LRR8 rs1388116497:A > G
647 G > A Silent216 LRR_RI rs1388116498:G > A
662 G > A Silent221 - rs1388116499:G > A
672 A > C Silent224 - rs1388116500:A > C
TLR9 2340 C > T Silent780 - rs1388116501:C > T
2475 A > G Silent825 - rs1388116502:A > G
aSNPs positions were calculated taking the ATG start codon as position 1 based on the sequences GenBank: HM756161 (TLR2 gene), GenBank: JN786600 (TLR4 gene),
GenBank: HQ242778 (TLR9 gene).
bAmino acid positions are given according to the ATG start codon.
cProtein domain has been predicted from the cds sequence by using the Conserved Domain Database available at
http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi [23,24].
dProtein position with unknown function.
eThis SNP is conserved also in the bovine species [9].
fThis polymorphic site exhibits a SNP with three different alleles (572 A > CG).
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egory used as a baseline (Table 3).
In the TLR2 gene, the 1650 G > A locus exhibited a
χ2 test of independence with a significant P-value (P =
0.018) while the OR for the AA genotype, calculated
with the Woolf ? s method, exhibited a not statistically
significant value (P = 0.0512, OR = 0.10, 95% CI = 0.01-
1.74). However, in this case, a significant test for trend
(P = 0.01) in calculating OR values in logistic regressionindicates a plausible strong correlation with resistance to
the disease.
For the TLR4 gene, the SNP 672 A > C showed a
χ2 test with a significant P-value (P = 0.031); the OR
demonstrated a significant P-value (P = 0.012) for the
CC genotype at the 672 A > C locus and a value lower
than 1 (OR = 0.26, 95% CI = 0.08 to 0.80), thus indi-
cating a significant association with resistance to
tuberculosis.
Table 2 Results of permutation analysis
Chromosome SNP Empirical P-value
17 42-C > T 0.9000
17 53-C > T 0.1967
17 108-C > T 0.1714
17 153-G > A 0.2195
17 156-C > T 0.9452
17 374-T > C 0.1229
17 381-A > G 0.9788
17 482/483-GC > CT 0.8222
17 519-G > C 0.5175
17 1034-A > G 0.2191
17 1375-T > C 0.1302
17 1407-C > T 0.8738
17 1650-G > A 0.0138*
17 1678-A > G 0.1505
17 1707-C > T 0.2203
17 1731-C > T 0.9286
17 1740-C > T 0.8985
17 2064-T > C 0.1296
3 572 C > A G 0.4909
3 574 C > T 0.4288
3 575 A > G 0.4380
3 576 T > G 0.2490
3 577 G > A 0.6373
3 579 A > G 0.2551
3 647 G > A 0.1735
3 662 G > A 0.1006
3 672 A > C 0.0183*
21 2340 C > T 0.0521*
21 2475 A > G 0.1254
*statistically significant.
Table 3 Polymorphic sites including genotypes with
statistically significant differences in frequency distribution
between cases and controls
Gene SNPs Genotype P-value OR CI 95%
TLR2 1650 G > A G/A 0.166 0.612 0.26 - 1.01
A/A 0.021 0.000 ?
TLR4 672 A > C A/C 0.689 0.865 0.42 - 1.76
C/C 0.012 0.258 0.08 - 0.80
TLR9 2340 C > T C/T 0.048 2.917 0.96 - 8.89
T/T 0.030 3.306 1.05 - 10.40
Bold lines highlight genotypes with statistically significant P-values and ORs.
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site (2340 C > T) with a significant P-value (0.053) at the
χ2 test including one genotype (T/T) associated with
susceptibility to the disease (P = 0.030 and OR = 3.31,
95% CI = 1.05-10.40).
Haplotype reconstruction based on TLR2 polymorphisms
performed by PHASE software, generated 25 possible
haplotypes, seven of which displayed a frequency greater
than 0.01% in the whole sample. The software PHASE can
reveal any significant imbalance in haplotype distribution
between groups by performing a permutation test; the
application of this analysis to the detected haplotypes
revealed the presence of one haplotype (CTTACCA
GCGGCCAGTCCC) associated with disease resistance
(P = 0.041 and OR= 0.51, 95% CI = 0.27-0.96). This haplo-
type contained the allelic variant that resulted possibly asso-
ciated with resistance to the disease.
In the TLR4 gene, 34 haplotypes were observed in the
two tested groups, six of which displayed a frequency
greater than 0.01% in the whole population. None of the
predicted haplotypes showed a significant association with
resistance/susceptibility to tuberculosis.
Finally, four haplotypes were observed in the TLR9 gene,
none of which displayed a significant association with
resistance/susceptibility to tuberculosis.
Discussion
The polymorphisms of single nucleotides constitute excel-
lent genetic markers for various population studies as they
can, for instance, reveal traces of natural selection. More-
over, it is now known that the contribution of genes to the
incidence of or predisposition to diseases can be deter-
mined by comparing inter-individual genetic differences.
Each individual, to a greater or lesser degree than others,
is genetically prone to develop certain diseases. In most
cases, the susceptibility or resistance to a given pathology
does not of course mean that the individual will necessarily
be affected by the disease or remain disease-free; it does,
however, indicate a higher or lower risk than that of the
general population. Indeed, the onset of symptoms is due
to an interaction between genetic factors and environmen-
tal factors. Nevertheless, cases have been described in
which genetic factors are sufficient to determine the course
of infection. In scrapie, for instance, which is a transmis-
sible disease of sheep and goats caused by a prion, there
are reports of genotypes that are defined as ? resistant? ,
which are practically refractory to natural infection [25,26].
Our analysis of the water buffalo TLR2, TLR4 and TLR9
genes enabled us to identify 29 SNPs. In the three genes,
the 76% of the SNPs fell within the LRR protein domains,
regions responsible for ligand recognition. This finding is
in agreement with conservation of the transmembrane
and functional TIR domains already observed in human,
bovine and murine TLRs genes [9-13].
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of associations between some of the identified polymor-
phisms and resistance/susceptibility to the disease caused
by M. bovis. Specifically, in TLR4, we observed a correl-
ation between resistance to disease and the genotype C/C
at the 672 A > C locus (P = 0.012, OR = 0.26, 95% CI =
0.08-0.80) when a logistic regression model was per-
formed. A likewise correlation with weak statistical
evidence was seen in TLR2 at the 1650 A >G locus when a
logistic regression model was performed between wild type
genotype and mutated genotype (P = 0.0512, OR = 0.10,
95% CI = 0.01-1.74). Moreover, a correlation was seen be-
tween susceptibility to tuberculosis and the T/T genotype
at the 2340 C > T locus in the TLR9 gene (P = 0.030,
OR = 3.31, 95% CI = 1.05-10.40).
Haplotype reconstruction based on TLR2 polymor-
phisms enabled us to ascertain whether the interaction
of the single alleles exerted an influence on the animal ? s
response to the disease; indeed, this analysis revealed a
haplotype (CTTACCAGCGGCCAGTCCC) that was as-
sociated with disease resistance (P = 0.041 and OR = 0.51,
95% CI = 0.27-0.96). This haplotype contained the allelic
variant which resulted possibly associated with resistance
to the disease. However, as this variant is not exclusive of
the associated haplotype, we may hypothesise that other
loci exert a modulatory effect.
Haplotype reconstruction and the permutation test con-
ducted on the polymorphisms identified in TLR4 did not
retrieve any disease-associated haplotype.
Previous studies have demonstrated the influence of
genetic factors and some gene polymorphisms on suscep-
tibility to several bacterial diseases, including TB. TLRs
have been found to be associated with both the innate im-
mune and adaptive immune responses, and play a crucial
role in the immune recognition of M. tuberculosis. Muta-
tions and polymorphisms in TLRs and TLR signalling
molecules have revealed the importance of TLRs both in
human and animal defence against disease [14-22,25-28].
One nsSNP in TLR2 (Arg753Gln) has been shown to in-
crease human predisposition to staphylococcal infection,
tuberculosis, rheumatic fever and urinary tract infection
[10-15]. A nsSNP in the bovine TLR2 gene (Val220Met)
has been shown to decrease the response to M. avium
subsp. paratuberculosis (Map) [11], while another SNP in
the same gene, C1903T (Silent569), was found to be asso-
ciated with resistance to Map infection in cattle [9]. Sev-
eral polymorphisms have been found in the bovine TLR4
gene, 12 SNPs affecting ligand binding domain [29] and
four SNPs associated with susceptibility to Map infection
[11]. Studies conducted on the bovine TLR9 gene demon-
strated a high degree of genetic variability in this gene
[14-22,25-30], even though no significant association with
bovine tuberculosis could be inferred from mutations in
this gene [14]. A SNP in the human TLR9 gene (rs352139)was found to be associated with susceptibility to TB
(P = 0.01, OR = 2.37) [31]. In our study, among the poly-
morphisms identified in water buffalo, only one (C1707T in
the TLR2 gene) showed correspondence to a polymorphism
reported in cattle (T1903C) [9]. Specifically, Koets and co-
workers [9] found this SNP associated with resistance to
Map, while in water buffalo the same polymorphism did
not show any significant association with susceptibility/
resistance to TB.
To date, it is estimated that about 50 human diseases
are caused entirely or partly by synonymous mutations,
and it has also been demonstrated that they play a role
in disease resistance [32,33]. In the human TLR2, for ex-
ample, synonymous mutations have been identified which
are associated with resistance to liver cell carcinoma [17].
A recent meta-analysis identified a significant association
between an intron mutation of TLR9 and tuberculosis in
humans [34].
Moreover, it has been observed that silent mutations
can interfere with various stages of protein ? construction? ,
from DNA transcription to the translation of mRNA into
protein.
Silent changes in codons located in the exonic splicing
enhancers (ESE) can prevent introns from being properly
eliminated. A notable example of the damage that can be
caused by mutations in a splicing enhancer has been doc-
umented for the CFTR (Cystic Fibrosis Transmembrane
Conductance Regulator) gene [35,36].
Finally, synonymous mutations can alter the stability of the
transcript by reducing its affinity for RNA binding proteins.
Indeed, in humans, a synonymous mutation of the gene cod-
ing for corneodesmosine (CDSN) has been associated with
the onset of psoriasis in various ethnic groups [37].
An alternative hypothesis could be that some of the
detected synonymous mutations are not directly related
to disease susceptibility/resistance, but rather that one
or more are linked to other functional mutations on the
same chromosome which have not yet been identified.
Functional studies will be crucial in order to understand
how these polymorphisms act.
Conclusions
The work describes novel mutations in the bubaline TLR2,
TLR4 and TLR9 genes and describes their association with
M. bovis infection. Studies of the genetic factors involved
in complex diseases have not yet provided clear explana-
tions for the onset of such diseases, though they may help
to identify their underlying physio-pathological pathways.
A thorough knowledge of these mechanisms will improve
our ability to determine the risk of developing the disease
and to understand it in its entirety. This will pave the way
to create multiple layers of disease resistance in herds by
selective breeding and also to identify and synthesize in-
novative drugs.
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Study design
Genetic association between SNPs and TB was studied
by a case-control approach on 184 water buffaloes from
22 herds in the Campania region. Sample collection was
performed within the Italian National Plan for the con-
trol of tuberculosis, which imposes culling of all the sub-
jects positive to the delayed hypersensitivity test [38]
and microbiological processing of the lymphoid tissue
for isolation of M. bovis [38]. Our analyses, performed
during the period 2009-2011, revealed the presence of
59 animals positive to both intradermal TB test and M.
bovis microbiological isolation. These 59 animals were
therefore classified as cases for the case-control study.
The choice of the microbiological test to confirm cases
identification was considered in order to exclude the
possibility of false-positive subjects diagnosed by the de-
layed hypersensitivity test. The control subjects were
collected among the animals which tested negative to re-
peated intradermal TB tests (at least three tests) during
the entire period of the study. The control animals were
at least five years-old, and were born and raised in theTable 4 PCR primers, annealing temperatures and amplicon l
Oligo Sequence (5′ 3′)
TLR2 A For: TTTGTAGGTCAAATCACTGGACA
Rev: TCCTGGCCACTGACAAGTTT
TLR2 B For: GCCCTTCCTTCAAACCTTG
Rev: CACCACCAGACCAAGACTGA
TLR4 A For: GTGTGGAGACCTAGATGACTGG
Rev: GTACGCTATCCGGAATTGTTCA
TLR4 B For: CTTTCCTGGAGGGACTGTGC
Rev: CCACGAAGTTTGAACCTAAGGTAA
TLR4 C For: CTACCAAGCCTTCAGTATCTAG
Rev: GGCATGTCCTCCATATCTAAAG
TLR4 D For: AAGGACCAGAGGCAGCTCTT
Rev: TAACTGAACACGCCCTGCAT
TLR9 A For: CCAGCCTCTCCTTAATCTCC
Rev: CGGAACCAATCTTTCTCTAGTT
TLR9 B For: CCTGACACCTTCAGTCACCT
Rev: GCGGGTAAACATCTCTTGCT
TLR9 C For: CGTCAGCTCAAAGGACTTCA
Rev: AGGGTGTGCAGATGGTTCTC
TLR9 D For: GGGAGACCTCTATCTCTGCTTT
Rev: CGCTCACGTCTAGGATTTTC
TLR9 E For: CTTCAGAAGCTGGACGTGAG
Rev: TCTTGCGGCTGCTGTAGAC
TLR9 F For: TGCTCTATGATGCCTTCGTG
Rev: AGGTTGGCCCAGAAACTACC
aFor these primer pairs a touchdown PCR thermal profile was used.same herds of cases to ensure an equal level of exposure
to infection. The number of controls was estimated tak-
ing into account an odds ratio value of 2.0 as a threshold
for significance, with a ratio for cases and controls of 1:2
(power = 80%, confidence = 95%) [12]. Based on these pa-
rameters, with an imposed number of cases (59), the re-
quired number of controls was 108 for a one-tailed analysis.
The present case-control study therefore included 59 cases
and 125 controls.
TLRs sequencing
DNA was extracted from blood (control animals) and
lymph node (cases) samples using the QIAamp DNA
mini kit (Qiagen, Hilden, Germany) according to the
manufacturer ? s protocol. PCR primers for amplification
of the CDS of the genes TLR2, TLR4 and TLR9 were de-
signed using the Web interface Primer3; they are shown
in Table 4. The TLR2 coding sequence was amplified
using two primer pairs according to the following touch-
down PCR protocol: initial step of 7 cycles of 1 min at
95?C, 1 min at 65?C (decreasing by 1?C after each cycle),
1 min 30 s at 72?C, followed by 35 cycles of 1 min at 95?C,ength of amplified bubaline TLRs 2, 4 and 9 genes
PCR Tann (?C) Amplicon (bp)
58a 1331 bp
58a 1234 bp
60 706 bp
60 435 bp
60 743 bp
58 801 bp
54 718 bp
55 651 bp
56 546 bp
56 428 bp
55 685 bp
55 424 bp
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at 72?C. The TLR4 CDS was amplified using four primers
sets with the following thermal profile: 35 cycles of 30 s at
95?C, 30 s at T ann and 45 s at 72?C, with a final extension
of 10 min at 72?C. T ann is the annealing temperature spe-
cifically indicated for each primers pair in Table 4. The
TLR9 CDS was amplified using six primer sets with the
following thermal profile: 5 cycles of 30 s at 95?C, 20 s at
60?C, and 15 s at 72?C followed by 30 additional cycles of
20 s at 95?C, 20 s at T ann, and 30 s at 72?C, with a final
extension of 10 min at 72?C. All thermal profiles included
an initial step at 95?C for 15 min for Taq DNA polymerase
activation. PCR reactions were performed with the
HotStar HiFidelity Polymerase Kit (Qiagen), and the reac-
tion mixture included 50 ng of genomic DNA and 0.5 μM
of each primer (forward and reverse) in a final volume of
25 μl. Amplicons were purified (QiaQuick purification
kit, Qiagen), bi-directionally sequenced using the Big
Dye Terminator cycle sequencing kit v.1.1 or v.3.1
(Life Technologies) and purified using the DyeEx spin
kit (Qiagen). Samples (5μl) were denatured with 10 μl
of Hi-Di formamide (Life Technologies) at 95?C for 5 min,
and separated by capillary electrophoresis on either ABI
PRISM 310 or 3130 sequencers (Life Technologies). Se-
quencing data were manually inspected by the Sequencing
Analysis software v5.4 (Life Technologies).
SNP selection and genotyping
Sequences were analyzed by multiple alignment using
BioEdit v.7.1.3 [39] and SeqManII 5.00 software (DNASTAR
Inc.). The 184 water buffalo sequences of the TLR2, TLR4
and TLR9 genes were compared with the publicly available
sequences GenBank:HM756161 (Toll-like receptor 2 gene,
complete cds), GenBank:JN786600 (Toll-like receptor 4
gene, complete cds), GenBank:HQ242778 (Toll-like receptor
9 gene, complete cds), respectively. Each forward and re-
verse sequence from a single DNA sample was compared
with the other in order to generate a consensus sequence
and to identify polymorphisms among the samples.
Genetic association analysis
Genotype frequencies were tested for deviation from
Hardy-Weinberg equilibrium (HWE) by using Fisher Exact
test and Chi-square test (χ2). Pearson? s χ2 test was carried
out for each SNP both independently and by using a mul-
tiple testing correction based on permutation [40,41].
SNPs that were significantly associated with the disease
were entered in an univariate logistic regression model.
All statistical analyses were performed using Stata statis-
tical software, release 10.0 (Stata Corp., College Station,
TX, USA) and PLINK software (PLINK 1.07, Shaun
Purcell http://pngu.mgh.harvard.edu/purcell/plink/).
Haplotype reconstruction was performed using PHASE
software, version 2.1 [42].Competing interests
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